Salta alla navigazione principale Salta alla ricerca Salta al contenuto principale

Skin toxicity following radiotherapy in patients with breast carcinoma: is anthocyanin supplementation beneficial?

  • Francesca Bracone
  • , Amalia De Curtis
  • , Augusto Di Castelnuovo
  • , Roberto Pilu
  • , Mariangela Boccardi
  • , Savino Cilla
  • , Gabriella Macchia
  • , Francesco Deodato
  • , Simona Costanzo
  • , Licia Iacoviello
  • , Giovanni De Gaetano
  • , Alessio Giuseppe Morganti
  • , Katia Petroni
  • , Chiara Tonelli
  • , Maria Benedetta Donati
  • , Chiara Cerletti
  • IRCCS Istituto Neurologico Mediterraneo Neuromed - Pozzilli (IS)
  • Mediterranea Cardiocentro
  • University of Milan
  • Gemelli Molise Hospital
  • University of Bologna

Risultato della ricerca: Contributo in rivistaArticolo

Abstract

Background: The EU-supported ATHENA project stems from a previous study suggesting that moderate wine consumption reduced the side-effects of radiotherapy (RT) in breast cancer patients, an effect possibly due to non-alcoholic anthocyanin fractions of wine. Objective: To evaluate the role of anthocyanins on RT skin side effects in breast cancer patients. Methods: Randomized, controlled, double-blind clinical trial. Patients were assigned to an intensity modulated radiation therapy (IMRT) either for three or five weeks, then randomized to receive three times a day a water-soluble anthocyanin (125 mg)-rich extract of corn cob or a placebo. Supplementation started one week before till the end of RT. Skin characteristics were detected by a standardized, non-invasive Cutometer® dual-MPA580, providing quantitative indices of skin maximal distensibility (R0), elasticity (R2, R5, R7) and viscoelasticity (R6); a Mexameter® MX18 probe evaluated the skin erythema (Er) and melanin (M). Measures were performed before (T0), at the end of RT and of supplementation (T1), and 1, 6 and 12 months after RT (T2-T4). Acute and late skin toxicity were scored according to the RTOG/EORTG scale. Selected biomarkers were measured at T0 and T1. Results: 193 patients previously assigned to 3- or 5-week RT schedules were randomized to either anthocyanin (97) or placebo (96) supplementation. RT induced changes in skin parameters: R0, R2, R5 and R7 decreased, while R6 increased; the changes in R0 and R6 continued in the same direction up to one year, while the others recovered towards basal values; Er and M peaked at T1 and T2, respectively, and returned to basal values at T4. Comparable skin changes were apparent in anthocyanin and placebo groups. A moderate RT-induced increase in total and HDL cholesterol and triglycerides was prevented by anthocyanins. Conclusions: Anthocyanin supplementation did not prevent RT-induced local skin toxicity. The supplementation was well tolerated and safe.
Lingua originaleInglese
pagine (da-a)2068-2077
Numero di pagine10
RivistaClinical Nutrition
Volume40
DOI
Stato di pubblicazionePubblicato - 2021

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

  1. SDG 3 - Salute e benessere
    SDG 3 Salute e benessere

Keywords

  • Anthocyanin
  • Cutometer-mexameter
  • Skin toxicity
  • Lipids
  • Radiotherapy
  • Inflammation

Fingerprint

Entra nei temi di ricerca di 'Skin toxicity following radiotherapy in patients with breast carcinoma: is anthocyanin supplementation beneficial?'. Insieme formano una fingerprint unica.

Cita questo